Back

Risk scores are helpful for defining optimal DAPT duration - CONTRA.

4 March 2018 (14:15 - 14:30)
Organised by:
Congress Presentation Part of: Great debate on STEMI: current controversies on antiplatelet management after the acute phase Acute Coronary Syndromes: Antiplatelet Agents Open Access Acute Cardiovascular Care 2018

About the speaker

Photo
Professor Andrzej Budaj

Grochowski Hospital, Centre of Postgraduate Medical Education, Warsaw (Poland)

9 More presentations in this session

Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - PRO.
Professor S. De Servi (Pavia, IT)
Slides Video
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - Rebuttal PRO.
Professor S. De Servi (Pavia, IT)
Video
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration - Rebuttal CONTRA.
Professor A. Budaj (Warsaw, PL)
Presentation thumbnail
Risk scores are helpful for defining optimal DAPT duration: Chairpersons conclusion.
Presentation thumbnail
It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - PRO.(Via ZOOM)
Professor P. Vranckx (Hasselt, BE)
Video

Access the full session

Session thumbnail
Great debate on STEMI: current controversies on antiplatelet management after the acute phase

The Event

Event poster

Acute Cardiovascular Care 2018

4 March 2018 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Risk score guided dual antiplatelet therapy duration in patients with acute coronary syndrome: insights from the FORCE-ACS registry
30 August 2024
thumbnail
Congress Presentation
Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
3 September 2019
thumbnail
Congress Presentation
New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group
28 August 2021
thumbnail
Congress Presentation
PRECISE-DAPT score for long-term bleeding prediction after acute coronary syndrome in patients managed without percutaneous coronary intervention
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources